SCHEMBL30865077

CC(C)C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 7)

	gene	UniProt	supporting neighbours	confidence
▸	NPY1R	P25929	1/20	0.55

▸	NPY2R	P49146	1/20	0.55

▸	NPY4R	P50391	1/20	0.55

▸	BACE1	P56817	4/20	0.53

▸	KISS1R	Q969F8	12/20	0.53

▸	BACE2	Q9Y5Z0	2/20	0.51

▸	OPRD1	P41143	1/20	0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30558099	0.98	NPY1R (0.54)	NPY1RNPY2RNPY4RBACE1KISS1R
SCHEMBL30184346	0.95	NPY4R (0.56)	NPY1RNPY2RNPY4RBACE1KISS1R
SCHEMBL29730544	0.95	NPY4R (0.58)	NPY1RNPY2RNPY4RBACE1KISS1R
SCHEMBL32691437	0.93	BACE1 (0.58)	NPY1RNPY2RNPY4RBACE1KISS1R
SCHEMBL29950752	0.93	NPY1R (0.55)	NPY1RNPY2RNPY4RBACE1KISS1R
SCHEMBL29530897	0.93	NPY4R (0.55)	NPY1RNPY2RNPY4RBACE1KISS1R
SCHEMBL29531366	0.93	NPY4R (0.55)	NPY1RNPY2RNPY4RBACE1KISS1R
SCHEMBL29496461	0.93	BACE1 (0.57)	NPY1RNPY2RNPY4RBACE1KISS1R
SCHEMBL29531210	0.93	NPY4R (0.55)	NPY1RNPY2RNPY4RBACE1KISS1R
SCHEMBL29403649	0.93	NPY4R (0.55)	NPY1RNPY2RNPY4RBACE1KISS1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20240041986-A1	METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF TYPE 1 DIABETES	DR. MARY MORRIS & ASSOCIATES, LLC (US)	2024-02-08	—	—	US	disclosed